At NuView Life Sciences Inc., we have a long-term vision for value creation. We focus on the future through prudent capital investment in medical research and development programs and by developing strategic business partnerships to expand our portfolio of medical products. This allows for the delivery of more cost effective diagnosis today and constantly improving patient outcomes.

We focus on identifying novel radiopharmaceutical technologies, developed at leading U.S. universities, for use in diagnosing cancer and heart disease. We license certain technologies from these universities with intellectual properties we believe have the potential for adoption and success, and further support those research programs and clinical partners to realize this potential.

Nuview partners with large and small healthcare companies to represent product lines. These combined medical device and pharmaceutical technologies personalize patient care, reduce medical costs and improve outcomes. We succeed when our customers and partners succeed with achievable benefits for the physicians, their patients and the communities they serve.

We hold ourselves, clinical investigators, partner companies and management teams to the highest standards and business practices. NuView believes that strong corporate governance, unique product research and development, innovative medical technologies and great customer service are the cornerstones of our business.